Applying the risk of bias tool in a systematic review of combination long-acting beta-agonists and inhaled corticosteroids for persistent asthma.
BACKGROUND: The Risk of Bias (RoB) tool is used to assess internal validity of randomized controlled trials (RCTs). Our objectives were to: 1) evaluate inter-rater agreement of the RoB tool; 2) determine the time to access supplemental study information; 3) compare the RoB tool with the Jadad scale...
Main Authors: | Lisa Hartling, Kenneth Bond, Ben Vandermeer, Jennifer Seida, Donna M Dryden, Brian H Rowe |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3044729?pdf=render |
Similar Items
-
The effect of adding long acting beta 2 agonists to inhaled corticosteroids versus increasing dose of inhaled corticosteroids in improving asthma control
by: Nisreen M. Nabil, et al.
Published: (2014-10-01) -
Montelukast as Add-On Therapy with Inhaled Corticosteroids or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (The RADAR Trial)
by: Paul K Keith, et al.
Published: (2009-01-01) -
Treatment persistence and exacerbations in patients with asthma initiating treatment with inhaled corticosteroids and beta-adrenergic agonists: retrospective cohort study
by: Fernández-Sánchez, T., et al.
Published: (2022) -
Real-Life Patterns of Exacerbations While on Inhaled Corticosteroids and Long-Acting Beta Agonists for Asthma over 15 Years
by: Michael J. McGeachie, et al.
Published: (2020-03-01) -
Drug Utilization Evaluation of Inhaled Corticosteroid and Long-Acting Beta2 Adrenergic Agonist Combination Therapy in Asthma Children
by: Ya-ChuanChang, et al.
Published: (2011)